Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977 Jun;4(3):351–355. doi: 10.1111/j.1365-2125.1977.tb00723.x

Plasma prednisolone levels in man following administration in plain and enteric-coated forms.

C G Wilson, C S May, J W Paterson
PMCID: PMC1429088  PMID: 901703

Abstract

1 Prednisolone plasma levels were measured in seven patients by a competitive protein binding method after administration of prednisolone (20 mg) by mouth as plain or enteric-coated tablets. 2 The mean peak plasma prednisolone concentration after the enteric-coated preparation, 199 ng ml-1, was significantly lower than after the plain tablet, 268 ng ml-1, and occurred later, at 4.69 h compared with 1.72 h. The bioavailability of the two preparations was similar. 3 It is concluded that, although the plasma concentration versus time profiles are different, the absorption of prednisolone from plain and enteric-coated preparations is equal.

Full text

PDF
352

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hulme B., James V. H., Rault R. Absorption of enteric and non-enteric coated prednisolone tablets. Br J Clin Pharmacol. 1975 Aug;2(4):317–320. doi: 10.1111/j.1365-2125.1975.tb02777.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. KAMMERER W. H., FREIBERGER R. H., RIVELIS A. L. Peptic ulcer in rheumatoid patients on corticosteroid therapy; a clinical, experimental and radiologic study. Arthritis Rheum. 1958 Apr;1(2):122–141. doi: 10.1002/art.1780010205. [DOI] [PubMed] [Google Scholar]
  3. KIRSNER J. B., PALMER W. L. The problem of peptic ulcer. Am J Med. 1952 Nov;13(5):615–639. doi: 10.1016/0002-9343(52)90028-4. [DOI] [PubMed] [Google Scholar]
  4. Leclercq R., Copinschi G. Patterns of plasma levels of prednisolone after oral administration in man. J Pharmacokinet Biopharm. 1974 Apr;2(2):175–187. doi: 10.1007/BF01061507. [DOI] [PubMed] [Google Scholar]
  5. PERKINS F. T., YETTS R., GAISFORD W. Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization. Br Med J. 1959 Mar 14;1(5123):680–682. doi: 10.1136/bmj.1.5123.680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. WEST H. F. Effects of prolonged adrenocortical stimulation on patients with rheumatoid arthritis. Ann Rheum Dis. 1957 Sep;16(3):322–333. doi: 10.1136/ard.16.3.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Wilson C. G., Ssendagire R., May C. S., Paterson J. W. Measurement of plasma prednisolone in man. Br J Clin Pharmacol. 1975 Aug;2(4):321–325. doi: 10.1111/j.1365-2125.1975.tb02778.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES